WuXi Online Forum II on COVID-19: Harnessing Our Collective Power
Date and time
Location
Online event
Description
WuXi Online Forum II on COVID-19: Harnessing Our Collective Power
7AM - 9AM PDT | 10AM - 12PM EDT | 4PM - 6PM CET | 10PM - 12AM Beijing Time
Thursday, April 16 | Live Global Webcast
At the COVID-19 pandemic spreads around the world, our industry has come together to wage a fierce battle against it. We have witnessed record speed and unprecedented collaborations on all fronts. Thank you for the efforts you have undertaken and those you will pursue in the months to come.
On April 16, we will extend the conversation in a second forum – “Harnessing Our Collective Power” - reflecting on progress to-date, lessons learned, and critical paths ahead as we combine our strengths to help the world out of this global health crisis. Led by science. Driven by dedication.
AGENDA in EDT Time Zone
10:00 – 10:04am
Welcome
Hui Cai, Vice President and Head of Content, WuXi AppTec
10:04 – 10:05am
Remembering the Lives Lost to COVID-19
10:05 – 10:25am
COVID-19: A Defining Moment
Jim Greenwood, CEO, Biotechnology Innovation Organization (BIO)
Moderated by Edward Hu, Co-CEO, WuXi AppTec
10:25 – 10:45am
Diagnosis: Lessons from the Battlefield
William Morice, President, Mayo Clinic Laboratories
Moderated by Carolyn Magill, CEO, Aetion
10:45 – 11:35am
Development in Time of Crisis
Johan Van Hoof, Global Therapeutic Area Head IDV, Vaccines, Janssen Pharmaceuticals R&D and Managing Director, Janssen Vaccines & Prevention, B.V.
Phil Pang, Chief Medical Officer, Vir Biotechnology
John Maraganore, CEO, Alnylam Pharmaceuticals
Chad Robins, CEO & Co-Founder, Adaptive Biotechnologies
Moderated by Steve Yang, EVP and CBO, WuXi AppTec
11:35 – 11:55am
The Future of Epidemic Readiness
Arnaud Bernaert, Head of Shaping the Future of Health and Healthcare, World Economic Forum
Moderated by Steve Usdin, Senior Editor and Head of Policy, BioCentury
11:55 – 12:05pm
Closing
Steve Bates, CEO, UK BioIndustry Association
This online Forum is brought to you by WuXi AppTec, WuXi Biologics, Morgan Stanley, Goldman Sachs, Huatai Securities, China Renaissance, UBS, Qiming Venture Partners, Frost & Sullivan, J&J Innovation, Deloitte, Zoom, Biocentury, AliHealth and Sina Medicine.